As of October 1st 2012, the Office of Biorepositories and Biospecimen Research (OBBR) has moved to the Cancer Diagnosis Program of the Division of Cancer Treatment and Diagnosis of the National Cancer Institute, […]
Select link below to view original article: http://www.biotech-now.org/health/2012/07/fda-safety-and-innovation-act-a-monumental-step-forward-for-patients-with-rare-diseases?utm_source=newsletter&utm_medium=email&utm_campaign=0711
Select link below to view original article: http://www.darkdaily.com/fast-growth-in-real-and-virtual-biobanks-may-be-revenue-opportunity-for-clinical-pathology-laboratories-052112#ixzz1vWgmYDcQ